The global hematopoietic stem cell transplantation market had a market value of US$ 7 billion in 2023 and is expected to reach a market value of US$ 15 billion by 2033, growing at an 8% CAGR from 2023 to 2033. The global hematopoietic stem cell transplantation industry is expected to grow significantly over the forecast period due to the increasing prevalence of leukaemia and lymphoma.
According to the Centers for Disease Control and Prevention (CDC), approximately 45,360 people in the United States were diagnosed with leukaemia in 2013, resulting in 23,549 deaths (13,625 men and 9,924 women). According to the same source, men are more likely than women to suffer from the illness. Leukemia accounts for about 3% of all new cancer cases.
To Get the Sample Copy of Report visit@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16462
Crucial information and forecast statistics covered in the Hematopoietic Stem Cell Transplantation market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.
COVID-19 Impact Analysis on Hematopoietic Stem Cell Transplantation Market
The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Hematopoietic Stem Cell Transplantation market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Hematopoietic Stem Cell Transplantation market.
Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.
The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Hematopoietic Stem Cell Transplantation market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.
Why Choose Future Market Insights
- Serving domestic and international clients 24/7
- Prompt and efficient customer service
- Data collected from reliable primary and secondary sources
- Highly trained and experienced team of research analysts
- Seamless delivery of tailor-made market research reports
Discounted prices for new customers! Offer expires soon!
Get in Touch With Our Team For Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16462
Hematopoietic Stem Cell Transplantation Market: Segmentation
Valuable information covered in the FMI’s Hematopoietic Stem Cell Transplantation market report has been segregated into key segments and sub-segments.
By Transplant Type:
- Allogeneic
- Autologous
By Indication:
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Multiple Myeloma
- Other Non-Malignant Disorders
By Application:
- Bone Marrow Transplant
- Peripheral Blood Stem Cells Transplant
- Cord Blood Transplant
Hematopoietic Stem Cell Transplantation Market: Competition Analysis
The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Hematopoietic Stem Cell Transplantation market. Competitive information detailed in the Hematopoietic Stem Cell Transplantation market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Hematopoietic Stem Cell Transplantation market report.
Key players covered in the report include:
- Pluristem Therapeutics Inc.
- CellGenix GmbH
- Regen Biopharma Inc.
- Lonza Group
- Sanofi
- Taiga Biotechnologies, Inc.
- Takeda Pharmaceutical Company Limited
- Escape Therapeutics, Inc.
- Bluebird Bio
- Talaris Therapeutics
Important Questions Answered in the Hematopoietic Stem Cell Transplantation Market Report
- Which end user remains the top revenue contributor in different regional markets?
- At what rate has the global Hematopoietic Stem Cell Transplantation market been expanding during the forecast period?
- How will the global Hematopoietic Stem Cell Transplantation market look like by the end of the forecast period?
- What innovative strategies are adopted by Hematopoietic Stem Cell Transplantation market players to stay ahead of the pack?
- What are the restraints affecting the growth of the global Hematopoietic Stem Cell Transplantation market?
Customization Available Upon Request@ https://www.futuremarketinsights.com/customization-available/rep-gb-16462
Key Offerings of the Report
- Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
- Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
- Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
- Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
- Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Hematopoietic Stem Cell Transplantation market
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs